drugset / Trial / NCT01762540

Glucocorticoid Induced Whole Body Catabolisme

NCT01762540

RandomizedCrossoverQuadruple-blindBasic science

Summary

The main purpose of the trial is to advance our knowledge on the possible mechanism underlying the catabolic effects of long-term treatment with glucocorticoid.

Timeline

Start
2013-01
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified 37.5 mg

Indications

No indication recorded.